Table 1 Clinicopathological features of patients with salivary gland-type lung carcinoma

From: Salivary gland-type lung carcinomas: an EGFR immunohistochemical, molecular genetic, and mutational analysis study

Case number

Age

Size

Histologic type

Grade

LN1

LN2

Local recurrence

Metastasis

 1

21

4.5

ACC

3

Liver

 2

36

5.5

ACC

2

 3

46

5.1

ACC

1

 4

47

2.8

ACC

2

+

+

Brain/lung/bone

 5

48

3.3

ACC

2

+

 6

51

4

ACC

2

+

 7

57

NA

ACC

2

+

+

Lung

 8

59

1.3

ACC

2

+

Lung

 9

61

>1.8

ACC

2

+

+

10

63

NA

ACC

2

+

11

66

1.8

ACC

3

12

76

2

ACC

2

13

18

2.4

MEC

1

14

21

2

MEC

2

15

24

2

MEC

1

16

28

2

MEC

1

17

36

1.2

MEC

1

18

40

1.5

MEC

2

19

40

1.8

MEC

1

20

41

1.6

MEC

2

21

47

3.5

MEC

2

22

61

3.3

MEC

2

+

Bone

23

63

4.5

MEC

2

24

65

0.9

MEC

2

+

  1. ACC, adenoid cystic carcinoma; MEC, mucoepidermoid carcinoma; NA, not assessable; LN1, metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, including intrapulmonary nodes involved by direct extension of the primary tumor lymph node metastasis; LN2, metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s).